Global Computational Biology Market to Reach US$ 28.3 Billion by 2032, Impelled by Increasing Need for Medicinal Drugs.

May 04, 2022 | Healthcare

According to the latest report by IMARC Group, titled "Computational Biology Market Report by Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), Services (In-House, Contract), End Use (Academics, Pharmaceutical Industry, Commercial), and Region 2024-2032," the global computational biology market reached a value of US$ 5.8 Billion in 2023. Computational biology refers to a branch of biology that involves the application of computer science to study the processes of life. It involves the utilization of various computational methods for the simulation and representation of biological systems on a large scale. Some of the popular adopted methods include algorithms, machine learning (ML), statistical physics, robotics and complexity theory that aid in determining the cellular function and treatment for multiple diseases. As a result, it is extensively used for examining atomic information, such as three-dimensional (3D) protein structure, bio-sequences of DNA, RNA and protein, and gene expression data.

Global Computational Biology Market Trends:

The global market is primarily driven by the increasing demand for medical drugs. This is supported by the escalating prevalence of chronic diseases due to the sedentary lifestyles led by the masses. Along with this, the rising funding for conducting extensive research and development (R&D) activities to introduce effective and safe therapeutic products that aid in the treatment of acute illnesses is creating a positive market outlook. In line with this, the recent outbreak of coronavirus disease (COVID-19) has further propelled the demand for computational biology worldwide. Additionally, continuous technological advancements, such as the widespread adoption of artificial intelligence (AI) in modern computational biology for predicting the molecular behavior of medical drugs, are favorably impacting the market. Furthermore, the increasing investments by private and public agencies to upgrade the existing healthcare infrastructure is acting as another major growth-inducing factor. Other factors, including the augmenting preference for clinical studies and a considerable rise in the number of research centers, laboratories and educational institutes, are also strengthening the market growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 28.3 Billion by 2032, exhibiting a CAGR of 18.8% during 2024-2032.

Market Summary:

  • On the basis of the application, the market has been segmented into cellular and biological simulation (computational genomics, computational proteomics, pharmacogenomics, and others), drug discovery and disease modelling (target identification, target validation, lead discovery, and lead optimization) preclinical drug development (pharmacokinetics and pharmacodynamics), clinical trials (phase I, phase II and phase III) and human body simulation software.
  • Based on services, the market has been segregated into in-house and contract.
  • On the basis of the end-use, the market has been classified into academics, pharmaceutical industry, and commercial.
  • Based on the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others) and the Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of these players include Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systèmes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrödinger Inc. and Simulations Plus Inc.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Application, Services, End Use, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systèmes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrödinger Inc. and Simulations Plus Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:


USA: +1-631-791-1145
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Computational Biology Market to Reach US$ 28.3 Billion by 2032, Impelled by Increasing Need for Medicinal Drugs.
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More